China Immunotech (Beijing) Biotechnology Co., Ltd.
华夏英泰（北京）生物技术有限公司
China
Time frame: 1 May 2025 - 30 April 2026Profile
The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The Nature Index provides absolute Count of primary research articles and fractional Share counts of author contribution to articles. The positions in the table below reflect China Immunotech (Beijing) Biotechnology Co., Ltd.'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the corresponding table where China Immunotech (Beijing) Biotechnology Co., Ltd. is listed.
Position by research output Share
Position by research output Share in subject areas
Research
China Immunotech (Beijing) Biotechnology Co., Ltd. has the following research output in the current window (1 May 2025 - 30 April 2026) of the Nature Index. Click on Count to view a list of articles representing the corresponding Share value.
Overall research output
Research outputs by subject area
Leading research topics
| Topics | Count | Share |
|---|---|---|
| Oncology and Carcinogenesis | 1 | 0.10 |
| Strategy, Management and Organisational Behaviour | 1 | 0.10 |
Share output for the past 5 years
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.
Collaboration
Nature Index collaborations highlight fruitful collaborations that lead to high quality research around the world. A collaboration can be between any two institutions or locations co-authoring at least one article in the journals tracked by the Nature Index. The collaboration score between two institutions is the sum of each of their Shares on the papers to which both have contributed. The table and charts below highlight the leading collaborators with China Immunotech (Beijing) Biotechnology Co., Ltd..
Top 5 domestic collaborators with China Immunotech (Beijing) Biotechnology Co., Ltd. by Share
Collaborating institutions
Note: Hover over the bars to view details about each institution's Share.
| Collaborating Institution | Collaborators' Share | Collaboration Score |
|---|---|---|
| International Joint Research Laboratory of Smart Construction | 0.10 / 0.27 | 0.37 |
| National Center of Technology Innovation for Digital Construction | 0.10 / 0.27 | 0.37 |
| China State Construction Technical Center | 0.10 / 0.13 | 0.23 |
| Tsinghua University | 0.10 / 0.08 | 0.18 |
| University of Chinese Academy of Sciences (UCAS) | 0.10 / 0.02 | 0.13 |
Top 5 international collaborators with China Immunotech (Beijing) Biotechnology Co., Ltd. by Share
Collaborating institutions
Note: Hover over the bars to view details about each institution's Share.
| Collaborating Institution | Collaborators' Share | Total Share |
|---|---|---|
| University of Maryland (UMD) | 0.10 / 0.09 | 0.19 |
| UCL | 0.10 / 0.09 | 0.19 |
| The University of Chicago (UChicago) | 0.10 / 0.02 | 0.13 |
Job finder
Need to hire scientific researchers?
Nature Careers is visited by over 180,000 active job seekers per month that you can target directly with your role. Application response rates have increased by 28% on average over 2022 averages.
Latest supplements
Nature Index 2026 Nanoscience and nanotechnology
From programmable RNA architectures to next-generation materials for energy and healthcare, researchers are harnessing the unusual properties of the nanoscale to tackle some of society's biggest challenges. This supplement explores the discoveries that are driving the field, the hurdles that remain and the institutions that are leading in nanoscience and nanotechnology research.
Nature Index 2026 Chemistry
Chemistry research is undergoing a period of transformation, driven by new technologies and mounting environmental pressures. In this supplement, we explore the trends behind China’s extraordinary rise in chemistry output, and why efforts to curb the use of PFASs are accelerating worldwide. We also look at the innovations that could redefine how chemicals are designed, produced and recycled.
